| Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine S Kanokudom, S Assawakosri, N Suntronwong, C Auphimai, P Nilyanimit, ... Vaccines 10 (1), 86, 2022 | 78 | 2022 |
| Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study N Wanlapakorn, N Suntronwong, H Phowatthanasathian, R Yorsaeng, ... Human vaccines & immunotherapeutics 18 (1), 2029111, 2022 | 73 | 2022 |
| Very high carriage of gametocytes in asymptomatic low-density Plasmodium falciparum and P. vivax infections in western Thailand W Nguitragool, I Mueller, C Kumpitak, T Saeseu, S Bantuchai, ... Parasites & vectors 10, 1-9, 2017 | 68 | 2017 |
| Asymptomatic and sub-microscopic malaria infection in Kayah State, eastern Myanmar MT Zaw, M Thant, TM Hlaing, NZ Aung, M Thu, K Phumchuea, K Phusri, ... Malaria journal 16, 1-7, 2017 | 63 | 2017 |
| Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults R Yorsaeng, N Suntronwong, H Phowatthanasathian, S Assawakosri, ... Vaccine 40 (3), 524-530, 2022 | 62 | 2022 |
| Neutralizing activities against the Omicron variant after a heterologous booster in healthy adults receiving two doses of CoronaVac vaccination S Assawakosri, S Kanokudom, N Suntronwong, C Auphimai, P Nilyanimit, ... The Journal of infectious diseases 226 (8), 1372-1381, 2022 | 53 | 2022 |
| Impact of COVID-19 public health interventions on influenza incidence in Thailand N Suntronwong, I Thongpan, W Chuchaona, F Budi Lestari, ... Pathogens and global health 114 (5), 225-227, 2020 | 51 | 2020 |
| Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients J Chansaenroj, R Yorsaeng, N Posuwan, J Puenpa, N Wanlapakorn, ... Scientific reports 11 (1), 23216, 2021 | 48 | 2021 |
| Safety and immunogenicity of inactivated COVID‐19 vaccine in health care workers S Benjamanukul, S Traiyan, R Yorsaeng, P Vichaiwattana, ... Journal of Medical Virology 94 (4), 1442-1449, 2022 | 39 | 2022 |
| Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020 J Puenpa, K Suwannakarn, J Chansaenroj, P Nilyanimit, R Yorsaeng, ... Scientific Reports 10, 2020 | 36 | 2020 |
| SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020 C Chirathaworn, M Sripramote, P Chalongviriyalert, S Jirajariyavej, ... PloS one 15 (10), e0236905, 2020 | 34 | 2020 |
| Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients J Chansaenroj, R Yorsaeng, N Posuwan, J Puenpa, N Sudhinaraset, ... Virology Journal 18, 1-7, 2021 | 33 | 2021 |
| Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020–2022 J Puenpa, P Rattanakomol, N Saengdao, J Chansaenroj, R Yorsaeng, ... Archives of Virology 168 (1), 26, 2023 | 32 | 2023 |
| Immunogenicity following two doses of the BBIBP-CorV vaccine and a third booster dose with a viral vector and mRNA COVID-19 vaccines against delta and omicron variants in prime … J Chansaenroj, N Suntronwong, S Kanokudom, S Assawakosri, ... Vaccines 10 (7), 1071, 2022 | 25* | 2022 |
| Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients J Chansaenroj, R Yorsaeng, J Puenpa, N Wanlapakorn, C Chirathaworn, ... PLoS One 17 (4), e0267102, 2022 | 25 | 2022 |
| COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against Omicron N Suntronwong, R Yorsaeng, J Puenpa, C Auphimai, T Thongmee, ... Vaccines 10 (3), 391, 2022 | 25 | 2022 |
| The impact of COVID-19 and control measures on public health in Thailand, 2020 R Yorsaeng, N Suntronwong, I Thongpan, W Chuchaona, FB Lestari, ... PeerJ 10, e12960, 2022 | 23 | 2022 |
| Immune response elicited from heterologous SARS-CoV-2 vaccination: Sinovac (CoronaVac) followed by AstraZeneca (Vaxzevria) R Yorsaeng, P Vichaiwattana, S Klinfueng, L Wongsrisang, ... medRxiv, 2021.09. 01.21262955, 2021 | 22 | 2021 |
| Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovaxᵀᴹ) after homologous and heterologous two-dose regimens S Kanokudom, J Chansaenroj, N Suntronwong, S Assawakosri, ... International Journal of Infectious Diseases 126, 64-72, 2023 | 19 | 2023 |
| Strong correlations between the binding antibodies against wild-type and neutralizing antibodies against Omicron BA. 1 and BA. 2 variants of SARS-CoV-2 in individuals following … N Suntronwong, S Assawakosri, S Kanokudom, R Yorsaeng, C Auphimai, ... Diagnostics 12 (8), 1781, 2022 | 18 | 2022 |
